1 / 5

Kevan Shokat , PhD

Kevan Shokat , PhD. Herman Suit Lecture CTOS 2013 New York, NY. Herman Suit, MD, DPhil, FASTRO. Organizational meeting 1993 CTOS 1 st meeting 1995 CTOS incorporated 1997. 2010. Kevan Shokat , PhD. Professor and Chair, Department of Cellular and Molecular Pharmacology, UCSF

bunme
Download Presentation

Kevan Shokat , PhD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. KevanShokat, PhD Herman Suit Lecture CTOS 2013 New York, NY

  2. Herman Suit, MD, DPhil, FASTRO Organizational meeting 1993 CTOS 1st meeting 1995 CTOS incorporated 1997 2010

  3. KevanShokat, PhD • Professor and Chair, Department of Cellular and Molecular Pharmacology, UCSF • Professor of Chemistry, UC Berkeley • HHMI Scientist, 2005- • National Academy of Sciences, 2010 • BA Chemistry, Reed College, 1986 • PhD Chemistry, UC Berkeley, 1991 (P. G. Shultz) • Postdoc-C.C. Goodnow 1992-4 • Princeton 1994-1999 • UC Berkeley and UCSF 1999- (Professor: 2001)

  4. PhD years Nature 1989; 338: 269

  5. By exploiting the highly conserved nature of the ATP binding site across the kinase superfamily and the availability of structural information from other protein kinases, we were able to engineer novel substrate specificity for v-Src without any detailed structural information about v-Src itself. That we used an unrelated kinase as a blueprint for designing orthogonal ATP analogs to tag the direct cellular substrates of v-Srcsuggests that this approach should work for other kinases as well. If it does, then it might be possible to systematically begin to dissect the complex proximal signaling cascades controlled by cellular tyrosine kinases.

More Related